Article Information
History
- November 23, 2021.
Article Versions
- You are currently viewing Version 1 of this article (November 23, 2021 - 07:55).
- Version 2 (February 9, 2022 - 07:18).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- AN Arumahandi de Silva1,†,
- LM Frommert1,†,
- FN Albach1,
- J Klotsche2,
- V Scholz1,
- LM Jeworowski3,
- T Schwarz3,
- A ten Hagen1,
- J Zernicke1,
- VM Corman3,4,
- C Drosten3,
- GR Burmester1,† and
- R Biesen1,†,*
- 1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- 2German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Berlin, Germany
- 3Institute of Virology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany
- 4Labor Berlin, Charité - Vivantes GmbH, Berlin, Germany
- ↵*Address correspondence and reprint request:
Dr. med. Robert Biesen, Department of Rheumatology and Clinical Immunology, Charité University Hospital, Charitéplatz 1, D-10117 Berlin – Germany, E-mail: Robert.Biesen{at}charite.de
↵† contributed equally